CBS 2019
CBSMD教育中心
中 文

Cardio-Oncology

Abstract

Recommended Article

Cardio-oncology: A Focus on Cardiotoxicity Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast Cancer Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery Drug-Drug Interactions of Common Cardiac Medications and Chemotherapeutic Agents Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients With Cancer Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction

Clinical Trial2017 Aug;47(1):133-142.

JOURNAL:Semin Arthritis Rheum. Article Link

Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study

Sparks JA, Barbhaiya M, Karlson EW et al. Keywords: Genetics; Methotrexate; Pharmacovigilance; Polyglutamate; Toxicity

FULL TEXT PDF